The company has also announced that William Rueckert has resigned from its board, and has accepted a position on the board of the company’s 72% shareholder, Novogen.
Ms Cann is an independent research analyst in Newport, Rhode Island. Ms Cann began her career as a research scientist with Memtec and moved to Wall Street in 1992, where she was a research analyst with CIBC Oppenheimer for nearly nine years.
Ms Cann has received a BA in art history and chemistry and an MBA from Stetson University.